Together with the results presented here, we propose that myeloid TGF-β signaling acts as a switch: the “ON” mode promotes immune suppression and metastatic outgrowth, while the “OFF” mode fosters anti-tumor immunity and tumor dormancy. The gene discussed is TGFB1; the disease is neoplasm.